Cannabis and Motivation: Does Smoking Really Make You Lazy?

Cannabis and motivation: The research at a glance

The so-called amotivational syndrome describes the hypothesis that long-term cannabis use can lead to indifference, passivity, poor goal orientation, and reduced willingness to perform.

This idea has been widespread for decades. However, it is much harder to prove scientifically than the stereotype of the “lazy stoner” suggests.

A systematic review by Skumlien and colleagues in 2021 examined the acute and non-acute effects of cannabis on reward processing, apathy, and anhedonia. The authors found evidence of changes in individual areas of reward processing, but also emphasized the inconsistent evidence and the need for larger longitudinal studies.

Source: Skumlien et al. (2021), The acute and non-acute effects of cannabis on reward processing: A systematic review.
Original source on PubMed

A systematic review even more specifically tailored to the question of motivation was published by Skumlien, Langley, and Sahakian in 2024.

The researchers examined recent human studies on acute and non-acute cannabis use. The results are particularly interesting for the question “Does cannabis make people lazy?”:

• The two acute studies included found a reduced willingness to exert effort for rewards.

• Of five newer non-acute studies with behavioral tasks, three found a higher willingness to exert effort for rewards.

• Two found no difference between cannabis users and controls.

• Most self-report studies also found no general differences in motivation.

• Indications of apathy were more likely to be associated with cannabis dependence.

This newer research therefore does not support the idea of a general amotivational syndrome occurring in all regular users.

Source: Skumlien M., Langley C., Sahakian B. J. (2024), Is Cannabis Use Associated with Motivation? A Review of Recent Acute and Non-Acute Studies.
Open-access original article on Springer Nature

You can also find information on the regulatory system involved in our post “What is the endocannabinoid system?“

THC binds, among other things, to CB1 receptors of the endocannabinoid system. This regulatory system is involved in numerous processes in the central nervous system – including reward processing and decision-making.

For the question of THC and motivation it is particularly interesting how our brain weighs effort against possible reward.

Under the acute effects of THC, an immediately pleasant and easy option may carry more weight than a task whose benefits only occur later.

This does not automatically mean that someone suddenly no longer finds their long-term goals important. However, it can influence in the short term how much effort a person is currently willing to invest in a goal.

What a controlled experiment shows

Lawn and colleagues examined in 2016 in the journal Psychopharmacology the acute and non-acute effects of cannabis on effort-based decisions and reward learning.

In the first study arm, 17 occasional users participated in a randomized, placebo-controlled crossover experiment.

They received either:

• vaporized cannabis with 8 mg THC,

• cannabis with 8 mg THC and 10 mg CBD,

• or placebo.

Subsequently, the participants completed the so-called Effort Expenditure for Rewards Task (EEfRT). In this task, people decide whether to choose a more demanding task for a possible higher reward.

Under the THC-dominant condition, the participants chose the higher-effort tasks less often than under placebo.

This provides controlled evidence that acute THC can reduce the willingness to invest effort for a possible reward.

However, the limitation is important: The sample consisted of only 17 people. Such an experiment cannot be used to infer whether regular cannabis use makes people unmotivated in the long term.

In the second part of the study, the researchers compared 20 cannabis-dependent people with 20 non-dependent, drug-experienced control subjects. At the time of the study, they were not acutely intoxicated.

In the effort-based decision-making task, there was no significant group difference. However, differences were found in reward learning.

Source: Lawn W. et al. (2016), Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses.
Original study on PubMed

You can find more background on dopamine and reward processing in our post “Serotonin and Dopamine – How Cannabis Affects Your Sense of Happiness“.

A short-term THC effect is not automatically the same as a long-term change in motivation.

A larger study from the CannTeen research program analyzed 274 adolescents and adults. The participants who consumed cannabis used it between one and seven days per week, on average about three to four days.

The researchers examined, among other things:

• Apathy,

• Anhedonia, i.e., reduced pleasure,

• Joy,

• and the willingness to invest physical effort for rewards.

The participants who consumed cannabis showed no higher apathy and no lower willingness to exert effort than the control group.

The control group even showed slightly higher anhedonia scores, although the difference was small.

These results contradict the simple idea that regular users are fundamentally pleasureless or unmotivated.

However, the study was cross-sectional. It therefore cannot prove a long-term cause-and-effect relationship.

Source: Skumlien M. et al. (2023), Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls.
Open-Access Full Text on PubMed Central

What a 2026 longitudinal study shows

A longitudinal fMRI study published in 2026 from the same research program provides an additional perspective.

Over twelve months:

• 46 cannabis-consuming adolescents and adults

• and 50 age-matched controls

were studied.

Over time, the activity in the right and left ventral striatum during the anticipation of non-drug-related rewards decreased more strongly in the cannabis-consuming participants compared to the control group.

The ventral striatum plays an important role in reward anticipation and motivation.

However, the observed effect sizes were small. Furthermore, a change in neural activity does not automatically prove that the individuals became less motivated or “lazier” in everyday life.

The authors also point out limitations such as the limited sample size, possible selection bias, and factors that cannot be fully controlled.

The study thus provides an interesting clue to possible longer-term changes in reward processing – but no evidence that regular smoking automatically leads to a lasting lack of motivation.

Source: Skumlien M. et al. (2026), The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controls.
Open-Access Original Article in Nature

The current state of research therefore does not provide a black-and-white picture:

Acute THC can influence motivation in the short term. However, regular consumption does not automatically lead to a lasting lack of motivation in everyone.

Anyone who notices that the required amount is increasingly increasing or that cannabis is becoming more and more self-evident in everyday life can find further background in our post “Joint Doesn't Work Anymore? Causes, Tolerance & What Really Helps“.

Two people can consume just as often and still develop completely different patterns.

Person A consumes occasionally in the evening, after work, exercise, and other obligations are completed.

Person B reaches for cannabis already in the afternoon when an unpleasant task is imminent or when feeling overwhelmed, lonely, or afraid of failure.

The mere number of consumption days only tells part of the story in this example.

If cannabis is regularly used to postpone unpleasant tasks or feelings, the short-term relief can reinforce an avoidance pattern.

The task does not disappear because of this. It simply feels less urgent temporarily.

Motivation therefore depends not only on pharmacological effects, but also on when, why, and in what situation it is consumed.

For personal assessment, the motivation for consumption can therefore be at least as interesting as the mere frequency of consumption.

Not every relaxed or unproductive evening is problematic.

The situation becomes relevant when a noticeable shift in everyday life develops over a longer period.

Possible warning signs include:

• Obligations are missed more frequently.

• Work, studies, or training suffer.

• Appointments are repeatedly postponed.

• Personal plans are regularly given up in favor of consumption.

• Earlier interests lose importance.

• Attempts to reduce consumption repeatedly fail.

• Cannabis increasingly takes precedence over other areas of life.

• Consumption continues despite noticeable negative consequences.

The World Health Organization describes, among other things, difficulty controlling the start, end, or extent of consumptionas a relevant feature of cannabis dependence.

Source: World Health Organization (WHO), technical information on cannabis.
WHO – Cannabis

The WHO has also published a detailed report on the health and social effects of nonmedical cannabis use.

WHO report: The health and social effects of nonmedical cannabis use

The National Academies of Sciences, Engineering, and Medicine also assessed possible links between cannabis use and education, employment, and social functioning.

For various psychosocial consequences, only limited evidence for statistical associations was found in some cases. A major problem is distinguishing cause from accompanying factors.

For example, someone who consumes cannabis regularly and is also less productive does not automatically have to be less productive because of the cannabis. 

Sleep problems, depressive symptoms, chronic stress, attention problems, and other stressors can also affect motivation and productivity.

Source: National Academies of Sciences, Engineering, and Medicine (2017), The Health Effects of Cannabis and Cannabinoids, Chapter 11: Psychosocial.
Chapter 11 in NCBI Bookshelf

If persistent lack of motivation, significant impairments in daily life, or other mental health problems occur, cannabis use should therefore not be considered as the sole factor. A professional assessment can help identify other possible causes.

Someone who primarily feels physically tired or sluggish after consumption should distinguish this from a lack of motivation. Tiredness and motivation can occur together, but they are not the same.

The question:

“Does cannabis make me lazy?”

is difficult to answer objectively.

More meaningful is a predefined and as concrete as possible self-observation.

Over a set period, the following points can be noted, for example:

• Time of consumption

• Approximate amount

• THC strength

• Duration of sleep

• Mood before consumption

• Reason for consumption

• Planned tasks

• Tasks actually completed

• Concentration the next day

Concrete observations are more helpful than general assessments.

Instead of:

“I was unmotivated today.”

for example, this is more helpful:

“I wanted to work on a task for one hour at 6 p.m., consumed beforehand, and did not start the task afterward.”

This makes possible connections more visible without prematurely labeling yourself as “lazy.”

Compare the time of consumption

One possible observation is to pay attention to whether tasks are more frequently left undone when consumption occurred before them than when consumption takes place only after completing obligations.

This makes it easier to assess whether the acute effects of THC are primarily associated with procrastination.

Compare cannabis-free days

Cannabis-free days can also make differences visible.

In doing so, not only productivity should be considered, but also:

• Sleep,

• Mood,

• Irritability,

• Inner restlessness,

• Concentration,

• Cravings for cannabis.

Use a planned break as a comparison

A longer break can provide additional clues as to whether cannabis use and lack of motivation are temporally related.

You can find more information in our article “Cannabis tolerance break: When do you really need one?”
To the Canasups article on the tolerance break

If motivation and concentration remain low during a longer cannabis-free period, other possible causes may come into sharper focus.

In cases of daily or medically supervised use, a significant change in consumption patterns should be discussed with a treating healthcare professional.

Anyone who repeatedly loses control over their consumption or cannot reduce it despite negative consequences should consider seeking professional support.

The WHO recommends screening and brief psychosocial interventionsfor adults who use cannabis. If problems persist or such brief interventions are insufficiently effective, further professional treatment can be considered. However, the WHO rates the evidence for this recommendation as very low.

Source: WHO – mhGAP: Brief psychosocial interventions.
WHO recommendations on brief psychosocial interventions

Acute THC can affect motivation in the short term. Controlled studies show that people under the influence of THC are sometimes less willing to invest more effort for a possible reward.

However, current research does not provide a clear picture of the idea that regular cannabis use automatically leads to a lasting amotivational syndrome 

More recent studies often find no generally higher apathy or lower willingness to exert effort among regular users. At the same time, there are indications that problematic or dependent use, as well as changes in reward processing, may play a role.

The cliché of the “lazy stoner” is therefore scientifically oversimplified. However, complete reassurance would also be unjustified.

What matters less than the label is the concrete development in daily life:

Do goals, work, relationships, and self-care remain stable – or are they increasingly subordinated to consumption?

1. Lawn W. et al. (2016)

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses.
Psychopharmacology (Berlin), 233(19–20), 3537–3552.
Randomized, placebo-controlled crossover experiment with 17 participants, as well as a non-acute group comparison with 20 cannabis-dependent and 20 control participants.
DOI: 10.1007/s00213-016-4383-x. PMID: 27585792.

Original study on PubMed

2. Skumlien M. et al. (2021)

The acute and non-acute effects of cannabis on reward processing: A systematic review.
Neuroscience & Biobehavioral Reviews, 130, 512–528.
Systematic review of the acute and non-acute effects of cannabis on reward processing, apathy, and motivation.
DOI: 10.1016/j.neubiorev.2021.09.008. PMID: 34509513.

Original source on PubMed

3. Skumlien M., Langley C., Sahakian B. J. (2024)

Is Cannabis Use Associated with Motivation? A Review of Recent Acute and Non-Acute Studies.
Current Behavioral Neuroscience Reports, 11, 33–43.
Review of recent human studies on acute and non-acute cannabis use, motivation, apathy, and willingness to exert effort.
DOI: 10.1007/s40473-023-00268-1.

Open-access original article on Springer Nature

4. Skumlien M. et al. (2023)

Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls.
International Journal of Neuropsychopharmacology, 26(1), 9–19.
Cross-sectional CannTeen analysis with a total of 274 adolescents and adults.
DOI: 10.1093/ijnp/pyac056. PMID: 35999024.

Open-access full text on PubMed Central

5. Skumlien M. et al. (2026)

The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controls.
Neuropsychopharmacology, 51, 1538–1545.
12-month longitudinal fMRI study with 46 cannabis users and 50 control participants.
DOI: 10.1038/s41386-026-02377-3.

Open-access original article on Nature

6. National Academies of Sciences, Engineering, and Medicine (2017)

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
Washington, DC: The National Academies Press.
Chapter 11: Psychosocial. Evaluation of evidence on education, employment, and social functioning, among other topics.

Chapter 11 on NCBI Bookshelf

7. World Health Organization (WHO)

The health and social effects of nonmedical cannabis use.
WHO report on the health, mental health, and social effects of cannabis use.

Original WHO report

8. World Health Organization – mhGAP

Brief psychosocial interventions.
WHO recommendations on screening, brief interventions, and possible follow-up treatment for problematic cannabis or stimulant use.

Current WHO recommendation